Cargando…

Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™)

PURPOSE: The aim of this study was to investigate the topical efficacy of a new purified extract from Madagascar, Gotu Kola (Centella asiatica [L.] Urban), both on human explants and on human volunteers, in relation to skin wrinkling and skin protection against ultraviolet light exposure. The extrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Maramaldi, Giada, Togni, Stefano, Franceschi, Federico, Lati, Elian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864881/
https://www.ncbi.nlm.nih.gov/pubmed/24376360
http://dx.doi.org/10.2147/CCID.S49924
_version_ 1782295962718306304
author Maramaldi, Giada
Togni, Stefano
Franceschi, Federico
Lati, Elian
author_facet Maramaldi, Giada
Togni, Stefano
Franceschi, Federico
Lati, Elian
author_sort Maramaldi, Giada
collection PubMed
description PURPOSE: The aim of this study was to investigate the topical efficacy of a new purified extract from Madagascar, Gotu Kola (Centella asiatica [L.] Urban), both on human explants and on human volunteers, in relation to skin wrinkling and skin protection against ultraviolet light exposure. The extract, with a peculiar content of biologically active molecules, was investigated as a novel anti-inflammaging and antiglycation agent. Its typical terpenes, known as collagen synthesis promoters, represent at least 45% of the extract. It also contains a polyphenolic fraction cooperating to the observed properties. METHODS: C. asiatica purified extract was assayed on human skin explants maintained alive, and several parameters were evaluated. Among the most relevant, the thymine dimerization was evaluated by immunostaining. Malondialdehyde formation was evaluated as free-radical scavenging marker by enzyme-linked immunosorbent assay. The expression of interleukin-1α was observed by enzyme-linked immunosorbent assay as well. The product was further evaluated as an antiglycation agent, being glycation quantified by the advanced glycation product carboxymethyl lysine. C. asiatica purified extract was also evaluated as an antiwrinkling agent in a single-blind, placebo-controlled study. Formulated in a simple oil-in-water emulsion, the extent of wrinkling was assessed by skin replicas, skin firmness, skin elasticity, and collagen density measurements. RESULTS: C. asiatica purified extract could protect DNA from ultraviolet light-induced damage, decreasing the thymine photodimerization by over 28% (P<0.05). A reduced (26%, P<0.01) expression of interleukin-1α was also observed, supporting its anti-inflammatory potential. C. asiatica purified extract showed in vitro a total inhibition of carboxymethyl lysine formation induced by the glycating agent methylglyoxal. A clear epidermal densification of collagen network in the papillary dermis was observed. These in vitro data have been confirmed by clinical results. CONCLUSION: These results qualify C. asiatica purified extract as an antiaging ingredient, addressing skin damage caused by inflammaging and glycation by relying on the synergy of triterpens and polyphenolics.
format Online
Article
Text
id pubmed-3864881
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-38648812013-12-27 Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™) Maramaldi, Giada Togni, Stefano Franceschi, Federico Lati, Elian Clin Cosmet Investig Dermatol Original Research PURPOSE: The aim of this study was to investigate the topical efficacy of a new purified extract from Madagascar, Gotu Kola (Centella asiatica [L.] Urban), both on human explants and on human volunteers, in relation to skin wrinkling and skin protection against ultraviolet light exposure. The extract, with a peculiar content of biologically active molecules, was investigated as a novel anti-inflammaging and antiglycation agent. Its typical terpenes, known as collagen synthesis promoters, represent at least 45% of the extract. It also contains a polyphenolic fraction cooperating to the observed properties. METHODS: C. asiatica purified extract was assayed on human skin explants maintained alive, and several parameters were evaluated. Among the most relevant, the thymine dimerization was evaluated by immunostaining. Malondialdehyde formation was evaluated as free-radical scavenging marker by enzyme-linked immunosorbent assay. The expression of interleukin-1α was observed by enzyme-linked immunosorbent assay as well. The product was further evaluated as an antiglycation agent, being glycation quantified by the advanced glycation product carboxymethyl lysine. C. asiatica purified extract was also evaluated as an antiwrinkling agent in a single-blind, placebo-controlled study. Formulated in a simple oil-in-water emulsion, the extent of wrinkling was assessed by skin replicas, skin firmness, skin elasticity, and collagen density measurements. RESULTS: C. asiatica purified extract could protect DNA from ultraviolet light-induced damage, decreasing the thymine photodimerization by over 28% (P<0.05). A reduced (26%, P<0.01) expression of interleukin-1α was also observed, supporting its anti-inflammatory potential. C. asiatica purified extract showed in vitro a total inhibition of carboxymethyl lysine formation induced by the glycating agent methylglyoxal. A clear epidermal densification of collagen network in the papillary dermis was observed. These in vitro data have been confirmed by clinical results. CONCLUSION: These results qualify C. asiatica purified extract as an antiaging ingredient, addressing skin damage caused by inflammaging and glycation by relying on the synergy of triterpens and polyphenolics. Dove Medical Press 2013-12-12 /pmc/articles/PMC3864881/ /pubmed/24376360 http://dx.doi.org/10.2147/CCID.S49924 Text en © 2014 Maramaldi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Maramaldi, Giada
Togni, Stefano
Franceschi, Federico
Lati, Elian
Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™)
title Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™)
title_full Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™)
title_fullStr Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™)
title_full_unstemmed Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™)
title_short Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™)
title_sort anti-inflammaging and antiglycation activity of a novel botanical ingredient from african biodiversity (centevita™)
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864881/
https://www.ncbi.nlm.nih.gov/pubmed/24376360
http://dx.doi.org/10.2147/CCID.S49924
work_keys_str_mv AT maramaldigiada antiinflammagingandantiglycationactivityofanovelbotanicalingredientfromafricanbiodiversitycentevita
AT tognistefano antiinflammagingandantiglycationactivityofanovelbotanicalingredientfromafricanbiodiversitycentevita
AT franceschifederico antiinflammagingandantiglycationactivityofanovelbotanicalingredientfromafricanbiodiversitycentevita
AT latielian antiinflammagingandantiglycationactivityofanovelbotanicalingredientfromafricanbiodiversitycentevita